Adobe

ByEd Silverman

Sept. 10, 2026

Pharmalot Columnist, Senior Writer

Ed Silverman

[email protected]

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morningPharmalittle newsletterand the afternoonPharmalot newsletter.

For years, drugmakers have offered free meals, samples, gifts, and speaking fees to physicians, a widely studied issue due to concerns such largesse may unduly influence prescribing habits.

But to what extent have interactions between doctors and pharmaceutical representatives changed behaviors over time?

Advertisement

A new analysis attempts to provide some answers. A group of researchers surveyed 283 physicians who were among more than 1,300 medical students and residents queried in 2011. They compared the responses to an updated effort that was undertaken two years ago, and the results suggest the topic is likely to remain contentious.

STAT+ Exclusive Story

Already have an account?Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account?Log in

Monthly

$39

Totals $468 per year

$39/monthGet Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 monthsGet Started

Then $399/year

Annual

$399

Save 15%

$399/yearGet Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A QuoteRequest A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/yearGet Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

SubscribeLog InPharmaceuticals

,

Policy

,

public health

,

STAT+Submit a correction requestReprints
  1. Ed Silverman

    Pharmalot Columnist, Senior Writer

    Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morningPharmalittle newsletterand the afternoonPharmalot newsletter.

Newsletter

From the lab to the medicine chest, these are the must-read drug industry updates of the day